293 related articles for article (PubMed ID: 32029330)
21. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
22. Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
Zhan T; Wang B; Fu J; Shao Y; Ye L; Shi H; Zheng L
Phytomedicine; 2021 Jan; 80():153381. PubMed ID: 33086170
[TBL] [Abstract][Full Text] [Related]
23. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.
Nguyen CQ; Kim H; Cornelius JG; Peck AB
J Immunol; 2007 Aug; 179(4):2318-29. PubMed ID: 17675493
[TBL] [Abstract][Full Text] [Related]
24. Myd88 is required for disease development in a primary Sjögren's syndrome mouse model.
Kiripolsky J; McCabe LG; Gaile DP; Kramer JM
J Leukoc Biol; 2017 Dec; 102(6):1411-1420. PubMed ID: 28951424
[TBL] [Abstract][Full Text] [Related]
25. Restoration of CFTR Activity in Ducts Rescues Acinar Cell Function and Reduces Inflammation in Pancreatic and Salivary Glands of Mice.
Zeng M; Szymczak M; Ahuja M; Zheng C; Yin H; Swaim W; Chiorini JA; Bridges RJ; Muallem S
Gastroenterology; 2017 Oct; 153(4):1148-1159. PubMed ID: 28634110
[TBL] [Abstract][Full Text] [Related]
26. Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjögren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis?
van Blokland SC; van Helden-Meeuwsen CG; Wierenga-Wolf AF; Drexhage HA; Hooijkaas H; van de Merwe JP; Versnel MA
Lab Invest; 2000 Apr; 80(4):575-85. PubMed ID: 10780673
[TBL] [Abstract][Full Text] [Related]
27. B7-H4 Inhibits the Development of Primary Sjögren's Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice.
Zheng X; Wang Q; Yuan X; Zhou Y; Chu H; Wang G; Li X; Wang Y; Wei L; Wang L; Li X
J Immunol Res; 2020; 2020():4896727. PubMed ID: 33062721
[TBL] [Abstract][Full Text] [Related]
28. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.
Daridon C; Pers JO; Devauchelle V; Martins-Carvalho C; Hutin P; Pennec YL; Saraux A; Youinou P
Arthritis Rheum; 2006 Jul; 54(7):2280-8. PubMed ID: 16802367
[TBL] [Abstract][Full Text] [Related]
29. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome.
Salomonsson S; Jonsson MV; Skarstein K; Brokstad KA; Hjelmström P; Wahren-Herlenius M; Jonsson R
Arthritis Rheum; 2003 Nov; 48(11):3187-201. PubMed ID: 14613282
[TBL] [Abstract][Full Text] [Related]
30. Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits.
Martínez Allo VC; Hauk V; Sarbia N; Pinto NA; Croci DO; Dalotto-Moreno T; Morales RM; Gatto SG; Manselle Cocco MN; Stupirski JC; Deladoey Á; Maronna E; Marcaida P; Durigan V; Secco A; Mamani M; Dos Santos A; Catalán Pellet A; Pérez Leiros C; Rabinovich GA; Toscano MA
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6630-6639. PubMed ID: 32161138
[TBL] [Abstract][Full Text] [Related]
31. Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment.
Hayashi Y; Haneji N; Hamano H; Yanagi K
Eur J Immunol; 1994 Nov; 24(11):2826-31. PubMed ID: 7957574
[TBL] [Abstract][Full Text] [Related]
32. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome.
Toda I; Sullivan BD; Rocha EM; Da Silveira LA; Wickham LA; Sullivan DA
Exp Eye Res; 1999 Oct; 69(4):355-66. PubMed ID: 10504269
[TBL] [Abstract][Full Text] [Related]
33. Sjögren's syndrome: an old tale with a new twist.
Lee BH; Tudares MA; Nguyen CQ
Arch Immunol Ther Exp (Warsz); 2009; 57(1):57-66. PubMed ID: 19219532
[TBL] [Abstract][Full Text] [Related]
34. Plasmacytoid dendritic cells promote the pathogenesis of Sjögren's syndrome.
Zhou J; Zhang X; Yu Q
Biochim Biophys Acta Mol Basis Dis; 2022 Feb; 1868(2):166302. PubMed ID: 34780913
[TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of Sjögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy.
van Blokland SC; Versnel MA
Clin Immunol; 2002 May; 103(2):111-24. PubMed ID: 12027416
[No Abstract] [Full Text] [Related]
36. Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome.
Scofield RH; Asfa S; Obeso D; Jonsson R; Kurien BT
J Immunol; 2005 Dec; 175(12):8409-14. PubMed ID: 16339583
[TBL] [Abstract][Full Text] [Related]
37. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
38. The possible etiopathogenic genes of Sjögren's syndrome.
Takei M; Shiraiwa H; Azuma T; Hayashi Y; Seki N; Sawada S
Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615
[TBL] [Abstract][Full Text] [Related]
39. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.
Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB
Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793
[TBL] [Abstract][Full Text] [Related]
40. A role for lymphotoxin in primary Sjogren's disease.
Shen L; Suresh L; Wu J; Xuan J; Li H; Zhang C; Pankewycz O; Ambrus JL
J Immunol; 2010 Nov; 185(10):6355-63. PubMed ID: 20952683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
